QuanDx/Zeesan Biotech’s MeltPro High Risk HPV Genotyping Assay is Effective for Cervical Cancer Screening for Women in Low- and Middle-Income Countries
May 28, 2019

GenomeWeb Reports a feature story on QuanDx HPV testing by Dartmouth research group led by Dr. Tsongalis

Unexpected Prevalence of Rare High-Risk HPV Types Demonstrates Utility of Zeesan Biotech Assay in Low-Resource Setting

May 29, 2019 | Madeleine Johnson

NEW YORK (GenomeWeb) – An evaluation of an HPV typing assay from Zeesan Biotech has shown the firm’s test kit can be incorporated successfully into an inexpensive screening protocol and run near patients in a low-resource setting. (More reading)

Related article published on Journal of Global Oncology can be found here.


Your Cart